# Tarsus Pharmaceuticals, Inc. (TARS): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/tars for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involve...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $68.20 USD |
| Market Cap | $3.19B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.09 |
| 52-Week Range | $53.89 – $91.53 |
| Dividend Yield (TTM) | — |

## Dividend

TARS has no dividend payment history in our records.

## Frequently Asked Questions

### What does Tarsus Pharmaceuticals, Inc. do?

Tarsus Pharmaceuticals, Inc. (TARS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is TARS's market cap?

Tarsus Pharmaceuticals, Inc. (TARS) has a market capitalization of approximately $3.19 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does TARS pay a dividend?

No, Tarsus Pharmaceuticals, Inc. (TARS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is TARS profitable?

Tarsus Pharmaceuticals, Inc. (TARS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has TARS ever paid a dividend?

No. Dividend Data's records show no dividend payments from Tarsus Pharmaceuticals, Inc. (TARS). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/tars
- Dividend history & safety: https://www.dividenddata.com/stocks/tars/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/tars/earnings
- Financial statements: https://www.dividenddata.com/stocks/tars/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/tars/valuation
- Peer comparison: https://www.dividenddata.com/stocks/tars/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.